Boris Klebanov

Boris Klebanov has a diverse work experience in the field of therapeutics, spanning over several years. Boris most recently worked at GO Therapeutics as a Scientist starting in August 2022. Prior to that, they were a Scientist at Verseau Therapeutics from August 2020 to April 2022. Before joining Verseau Therapeutics, Boris held the position of Senior Associate Scientist at Jounce Therapeutics, Inc. from May 2017 to August 2020. Boris also worked as a Scientist at Karyopharm Therapeutics Inc. from January 2012 to December 2016. Additionally, Boris served as a Senior Research Associate at Alnylam Pharmaceuticals from March 2008 to January 2012 and as an Associate Scientist at Biogen Idec from March 2007 to March 2008.

Boris Klebanov completed their education with a Master of Science degree in Pharmaceutical Sciences from Northeastern University, starting in 2004 and finishing in 2007. Prior to that, they obtained a Master of Arts degree in Biochemistry from Clark University, attending from 1998 to 2002. Boris also attended Brookline High from 1996 to 1998, but no specific degree or field of study was provided for this period.